Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | UNK | — | — |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Client vaccinated at an in-school event on 3/18/2025 partnered between the local school system and local health department. VIIS record was checked and was incomplete as the client was from another state. The client also only consented to receive the Tdap vaccine. Client received both Tdap and MenACWY but, upon post administration review of out-of-state records 3/19/2025 given to the school prior, the client had already received MenACWY. On 3/19/2025 the parent was called and notified of the medication error. The client was assessed by the school nurse and was found to not have any adverse signs or symptoms. School nurse educated the client on self monitoring for adverse vaccine reactions.